It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

16

L/RAIN

TOKYO (3 p.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Shionogi

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japanese firms turn to four-day week to improve work-life balance

Business | FOCUS May 3, 2022

Japanese firms turn to four-day week to improve work-life balance

by Ayano Shimizu

Companies open to the arrangement are hoping staff will acquire new skills or develop a network of contacts through additional education or a second job.

U.S. in talks with Japan's Shionogi to buy new COVID-19 pill

Business / Corporate Apr 22, 2022

U.S. in talks with Japan's Shionogi to buy new COVID-19 pill

Shionogi's treatment is in late-stage clinical trials and hasn’t yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.

Shionogi to recommend pregnant women not use oral COVID drug

National Apr 13, 2022

Shionogi to recommend pregnant women not use oral COVID drug

Shionogi has filed for conditional early approval to skip the final stage of clinical trials once a certain level of efficacy and safety has been confirmed.

Shionogi signs supply deal with Japanese government for COVID-19 pill

Business / Corporate Mar 25, 2022

Shionogi signs supply deal with Japanese government for COVID-19 pill

The government is considering buying a million doses of the drug, pending regulatory approval.

Japanese firms near domestic rollout of their COVID-19 vaccines

National | FOCUS Mar 15, 2022

Japanese firms near domestic rollout of their COVID-19 vaccines

by Osamu Tsukimori

Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.

Shionogi says its COVID-19 shot is effective and safe

National Mar 6, 2022

Shionogi says its COVID-19 shot is effective and safe

by Kanoko Matsuyama and Grace Huang

The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.

Shionogi seeks approval for Japan’s first domestic COVID pill

National / Science & Health Feb 25, 2022

Shionogi seeks approval for Japan’s first domestic COVID pill

by Osamu Tsukimori

Kishida has signaled that the central government will expedite the review process to pave the way for a swift approval if the drug's efficacy and safety are confirmed.

Shionogi and hospital to research development of nasal COVID-19 vaccine

National / Science & Health Feb 10, 2022

Shionogi and hospital to research development of nasal COVID-19 vaccine

The firm has also developed an oral COVID-19 vaccine and is expected to apply for approval as early as next week following clinical trials that showed its effectiveness.

Japan to consider early approval for Shionogi COVID-19 pill

National Feb 8, 2022

Japan to consider early approval for Shionogi COVID-19 pill

The company could file for early approval of the drug as soon as next week, and it could deliver enough doses for 1 million people by the end of March.

Shionogi delays filing for COVID-19 drug approval

National Jan 5, 2022

Shionogi delays filing for COVID-19 drug approval

The delay was due to the lack of enough participants for a clinical trial of the oral drug currently being developed by the pharmaceutical firm.

Tardy COVID-19 vaccine makers under fire for trials in developing nations

Business Dec 27, 2021

Tardy COVID-19 vaccine makers under fire for trials in developing nations

by Kanoko Matsuyama

Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.

Japanese drugmaker Shionogi considers developing vaccine for omicron variant

National / Science & Health Nov 30, 2021

Japanese drugmaker Shionogi considers developing vaccine for omicron variant

The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Japanese researcher suggests ties between omicron variant and severe hepatitis in children
    The omicron variant of the coronavirus as seen through a microscope
  • When will Japan open to tourists?
    Mount Fuji, one of Japan's most popular tourist attractions, in fall.
  • Sex, murder and a getaway car: ‘Ride or Die’ stars go on the trip of a lifetime
    All the right moves: The production team for “Ride or Die” hired an intimacy coordinator to coach the film’s two leads, Kiko Mizuhara (right) and Honami Sato (left), through sex scenes. Netflix says this was a first for a Japanese movie.
  • Japan detects first cases of BA.4 and BA.5 omicron in airport screening
    Haneda Airport on April 29
  • Kishida hints for first time at easing Japan's mask standards
    Prime Minister Fumio Kishida adjusts his face mask as he attends a news conference in Tokyo last month.
  • Biracial Okinawans begin to find voice amid tensions over U.S. bases

    Thumbnail image
  • Neutral Switzerland leans closer to NATO in response to Russia

    Thumbnail image
  • Marie Kondo is here to tidy up your pandemic clutter — if you want to

    Thumbnail image
  • Tourism and logistics: Okinawa's latest plan to boost its economy

    Thumbnail image
  • Documenting Okinawa's changing identity over the past half century

    Thumbnail image

PODCAST

  • DEEP DIVE

    When will Japan open to tourists?

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times